The impact of haemodialysis-associated variables on lipid profile in Egyptian haemodialysis population

International Urology and Nephrology

Volumn 39, Issue 2, 2007, Pages 609-618

  Abo Zenah, H ^a,c   Sabry, A ^b   Farouk, A ^b   Abdelhalim, N ^b   El Sayed, K ^b   Sobh, M ^b  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b MANSOURA UNIVERSITY   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Clinical; Hemodialysis; Lipid profile; Low molecular weight heparin

Indexed keywords

ACETIC ACID; BICARBONATE; BUFFER; CLEXAN; ENOXAPARIN; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYSULFONE; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DIALYSIS MEMBRANE; DIET RESTRICTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; EGYPT; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEMBRANE FILTER; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL; EGYPT; FEMALE; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 34447339359     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-9162-x     Document Type: Article

References (56)

1. Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1995) Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 91:831-37
2. Raine AEG (1992) Report on management of renal failure in Europe XXII, 1991. Nephrol Dial Transplant 7:7-35
3. Attman P-O, Samuelsson O, Alaupovic P (1993) Lipoprotein metabolism and renal failure. Am J Kidney Dis 21:573-92
4. Jamoussi K, Ayedi F, Abida N, Kamoun K, Feki H, Chaabouni MN, Hammouda F, Bahloul I, Bellaj A, Hachicha J, Ellouz F (2005) Lipid profile in maintenance haemodialysis Abstract. Pathol Biol (Paris) 53:217-20
5. Okubo M, Naito M, Nakamura M (2001) Abnormal lipid metabolism in chronic renal failure. Rev Abst. Nippon Rinsho. 59(Suppl 3):156-61
6. Oi K, Hirano T, Sakai S, Kawaguchi Y, Hosoya T (1999) Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int 71:S227-S28
7. Vaziri ND (2006) Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Rev Am J Physiol Renal Physiol. 290:F262-72
8. Yigitoglu MR, Polat MF, Akcay F, Ari Z, Uyanik BS, Ozilgili HM (1997) Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis. Abstr. Jpn Heart J 38:83-89
9. Horkko S, Huttunen K, Korhonen T, Kesaniemi YA (1994) Decreased clearance of low-density lipoprotein in patients with chronic renal failure. Kidney Int 45:561-70
10. Bergesio F, Monzani G, Ciuti R, Serruto A, Benucci A, Frizzi V, et al (1992) Lipids and apolipoproteins change during the progression of chronic renal failure. Clin Nephrol 38:264-70
11. Yang WQ, Song NG, Ying SS, Liang HQ, Zhang YJ, Wei MJ, Wu KF (1999) Serum lipid concentrations correlate with the progression of chronic renal failure. Clin Lab Sci 12:104-08
12. Cheung AK, Papker CJ, Ren K (1996) Increased lipase inhibition in uremia. Identification of pre-β-HDL as a major inhibitor in normal and uremic plasma. Kidney Int 49:1360-71
13. Oda H, Keane WF (1997) Recent advances in statins and the kidney. Kidney Int 52:S36-38
14. Mekki K, Bouchenak M, Lamri M, Remaoun M, Belleville J (2002) Changes in plasma lecithin: Cholesterol acyltransferase activity, HDL(2), HDL(3) amounts and compositions in patients with chronic renal failure after different times of hemodialysis. Atherosclerosis 162:409-17
15. Gillett MP, Obineche EN, El-Rokhaimi M, Lakhani MS, Abdulle A, Sulaiman M (2001) Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia. J Nephrol 14:472-80
16. Mekki K, Bouchenak M, Remaoun M, Belleville JL (2004) Effect of long-term hemodialysis on plasma lecithin: Cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: A 9-year longitudinal study. Med Sci Monit 10:CR439-46
17. Senti M, Romero R, Pedro-Botet J, Pelegri A, Nogues X, Rubies-Prat J (1992) Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41:1394-99
18. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, et al (1995) High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48:820-26
19. Shoji T, Nishizawa Y, Kawasaki K, Kawasaki K, Taniwaki H, Tabata T, et al (1998) Intermediate density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol 9:1277-84
20. Fytili CI, Progia EG, Panagoutsos SA, Thodis ED, Passadakis PS, Sombolos KI, Vargemezis VA (2002) Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients. Ren Fail 24:623-30
21. Arnadottir M, Kurkus J, Nilson-Ehle P (1994) Different types of heparine in hemodialysis: Long-term effect on post-heparin lipases. Scand J Clin Lab Invest 54:515-21
22. Wanner C, Bahner U, Mattern R, Lang D, Passlick-Deetjen J (2004) Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients. Nephrol Dial Transplant. 19:2570-75
23. Vanustel JL, Lins RL, Zachee P, Mattheussen J, Hosten S, Lens S, Daelemans R (1999) Comparison of different routes of administration of nadroparine in hemodialysis. Clin Nephrol 52:322-25
24. Lai KN, Ho K, Li M, Szeto CC (1998) Use of single dose low molecular weight heparin in long hemodialysis. Int J Artif Organs 21:196-200
25. Rao M, Sharm M, Junaja R, Jacob S, Jacob CK (2000) Calculated nitrogen balance in hemodialysis patients: Influence of protein intake. Kidney Int 58:336-45
26. Tattersall J, Farrington K, Greenwood R (1998) Adequacy of dialysis. In: Oxford test book of clinical nephrology, 2nd edn. Oxford University Press, Oxford, New York, Tokyo. By Davison AM, Cameron JJ, Crunfield JP, Kerr DNS, Ritz E, Winearls CG, Volume 3, Chapter 12, 2075-2088
27. Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-80
28. Trinder P (1969) Enzymatic colorimetric test with lipid clearing factor. Ann Clin Biochem 6:24-27
29. Abell LL, Levy BB, Brody BB, Kendall FE (1952) A simplified method for the estimation of total cholesterol in serum and a demonstration of its specificity. J Biol Chem 195:357-66
30. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470-75
31. Friedwald WT, Levey RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol without the use of preparative ultracentrifuge. Clin Chem 18:499-502
32. Labeur C, Michiels G, Bury J, Usher DC, Rosseneu M (1989) Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin Chem 35:1380-84
33. Rosner B (1990) Fundamentals of biostatistics, third edition. Boston, PWS Kent
34. Chittinandana A, Chailimpamontree W, Chaloeiphap P (2006) Prevalence of chronic kidney disease in Thai adult population. J Med Assoc Thai 89(Suppl 2):S112-S20
35. David A. Goodkin, Jennifer L. Bragg-Gresham, Karl G. Koenig, Robert A. Wolfe, Takashi Akiba, Vittorio E. Andreucci, Akira Saito, Hugh C. Rayner, Kiyoshi Kurokawa, Friedrich K. Port, Philip J. Held, Eric W. Young (2003) Association of Comorbid Conditions and Mortality in Hemodialysis Patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14:3270-77
36. van Dijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Gronhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD (2001) ERA-EDTA registry. Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 16:1120-29
37. Hellstrom L, Blaak E, Hagstrom-Toft E (1996) Gender differences in androgenic regulation of lipid mobilization during exercise. Int J Sports Med 17:439-47
38. Sayegh R and Lim VS. Endocrine disturbances In Handbook of Dialysis. Eds. Duagridas JT, Blake PG, and Ing TS. Third Edition, Lippincot Williams and Wilkins (2001) 29, pp. 522
39. Nicholls AJ. Heart and Circulation. In Handbook of Dialysis. EdsDuagridas JT, Blake PG, and Ing TS. 3 Ed, Lippincot Williams and Wilkins (2001) 33, pp. 583-600
40. Dejanova B, Filipee V, Dejanova P, Sikole A, Grozdanovski R, Maleska V (2001) Atherosclerosis risk factors related to hemodialysis duration and erythropoietin therapy. Clin Chem Lab Med 3:484-86
41. Odamaki M, Furuya R, Ohkawa S, Yoneyama T, Nishiking M, Hishida A, Kumagai H (1991) Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic hemofiltration and continuous hemodiafiltration. Contrib Nephrol 93:215-17
42. Piperi C, Kalofoutis C, Tzivras M, Troupis T, Skenderis A, Kalofoutis A (2004) Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients. Mol Cell Biochem 265:57-61
43. Diepeveen SH, Verhoeven GH, van der Palen J, Dikkeschei BL, van Tits BL, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF (2005) The effect of the initiation of renal replacement therapy on lipid profile and oxidative stress during the first 6 months of treatment. Clin Chim Acta 361:112-18
44. Jamoussi K, Ayedi F, Abida N, Kamoun K, Feki H, Chaabouni MN, Hammouda F, Bahloul I, Bellaj A, Hachicha J, Ellouz F (2005) Lipid profile in maintenance haemodialysis. Abstract. Pathol Biol 53:217-20
45. Kalantar-Zadeh K, Kilpatrick RD, Kopple JD, Stringer WW (2005) A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls. Hemodial Int 9:314-24
46. Shostka GD, Tiagi S, Rumiantsev ASh, Kozlov VV, Smirnov AV, Kulikova AI (1990) The effect of acetate and bicarbonate hemodialysis on protein and lipid metabolism in patients with chronic kidney failure. Abstract. Ter Arkh 62:88-92
47. Jung K, Scheifler A, Schulze BD, Scholz M (1995) Lower serum high-density lipoprotein-cholesterol concentration in patients undergoing maintenance hemodialysis with acetate than with bicarbonate. Am J Kidney Dis 25:584-88
48. Tanaka H, Nishikawa O, Yukawa S, Yoshimoto M, Nishide I (1999) Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients. Abstr. Nippon Jinzo Gakkai Shi. 41:1-7
49. Ottosson P, Attman PO, Knight C, Samuelsson O, Weiss L, Alaupovic P (2001) Do high-flux dialysis membranes affect renal dyslipidemia? Abstr. ASAIO J 47:229-34
50. Docci D, Capponcini C, Mengozzi S, Baldrati L, Neri L, Feletti C (1995) Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron 69:323-26
51. de Precigout V, Higueret D, Larroumet N, Combe C, Iron A, Blanchetier V, Potaux L, Aparicio M (1996) Improvement in lipid profiles and triglyceride removal in patients on polyamide membrane hemodialysis. Blood Purif 14:170-76
52. Elisaf MS, Germanos NP, Bairaktari HT, Pappas MB, Koulouridis EI, Siamopoulos KC (1997) Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients. Am J Nephrol. 17:153-7
53. Lai KN, Ho K, Cheung RC, Lit LC, Lee SK, Fung KS, Tong MK, Lam CW (2001) Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis. Int J Artif Organs 24:447-55
54. Stefoni S, Cianciolo G, Donati G, Coli L, La Manna G, Raimondi C, Dalmastri V, Orlandi V, D'Addio F (2002) Standard heparin versus low-molecular-weight heparin. A medium-term comparison in hemodialysis. Nephron. 92:589-600
55. Vlassopoulos D, Noussias C, Hadjipetrou A, Arvanitis D, Logothetis E, Magana P, Katopodis K, Hadjiconstantinou V (1997) Long-term effect of low molecular weight heparin on serum lipids in hypertriglyceridemic chronic hemodialysis patients. J Nephrol 10:111-14
56. Katopodis KP, Elisaf M, Balafa O, Nikolopoulos P, Bairaktari E, Katsaraki A, Siamopoulos KC (2004) Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: A pilot study. Am J Nephrol 24:469-73